Pulmonx Corporation (LUNG) Profit Margins
Over the twelve months to 2026-06-30, Pulmonx Corporation (LUNG) had gross margin 77.1%, operating margin -53.0%, net margin -55.0%, free cash flow margin -35.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LUNGPulmonx CorporationFollow LUNG — free
—
Price chart with a free account
- Market cap
- 78.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Oct, in 2 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 64.8% | 73.6% | 74.3% | 73.9% | 74.0% | 74.2% | 77.1% | |
| Operating margin | -98.8% | -97.7% | -109.3% | -90.2% | -68.9% | -59.3% | -53.0% | |
| Net margin | -98.5% | -100.5% | -109.8% | -88.6% | -67.3% | -59.7% | -55.0% | |
| FCF margin | -96.4% | -93.1% | -86.5% | -55.9% | -39.4% | -36.3% | -35.1% |
USD millions · SEC XBRL
Pulmonx Corporation — questions
- What is Pulmonx Corporation's gross margin?
- 77.1% over the twelve months to 2026-06-30.
- What is Pulmonx Corporation's operating margin?
- -53.0% over the twelve months to 2026-06-30.
- What is Pulmonx Corporation's net profit margin?
- -55.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Pulmonx Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.